Prostate MRI

Prostate Cancer: Over 230,000 New Cases Will Be Diagnosed and 30,000 Men Will Die This Year

Prostate Cancer is a growing problem for men around the world. In the United States alone, over 230,000 new cases will be diagnosed this year and 30,000 men will die.

MEDRAD, a leading provider of medical devices and services that improve the quality of healthcare, believes that Prostate MRI can make a difference.

Our Prostate eCoil™, 2006 winner of Frost & Sullivan's Product Differentiation Innovation Award, is a way for physicians and patients to get closer to the problem and closer to the solution. Not only does the eCoil contact the prostate during the imaging procedure, but the balloon tip conforms to its size and shape. The result is excellent images that physicians can use in proper diagnosis and treatment planning for prostate cancer.

The eCoil may be a solution for:

• High PSA, repeat negative biopsy
• Distinguishing between intracapsular and extracapsular disease
• Tumor localization and characterization
• Clarifying local recurrence, and
• Treatment planning

Prostate MRI using MEDRAD's eCoil is a newer imaging option, but one that could make a difference in prostate cancer.